Stoian M, Suru M, Zaharia O, Constantinescu E, Fleshler B A, Nastac E
Virologie. 1987 Jan-Mar;38(1):35-40.
SV40 antigen was detected on sections through malignant oromaxillofacial tumors in 47.8% of the cases, with a higher incidence among the epithelium originating tumors. Anti-SV40 CF antibodies were detected in 83.6% of the examined subjects with cancer, but only in 57.9% of the blood donors. The titers were quite low in general. The results are discussed from the point of view of the immunologic status of the patients.
在47.8%的口腔颌面恶性肿瘤切片中检测到SV40抗原,上皮源性肿瘤中的发生率更高。在83.6%的癌症患者中检测到抗SV40补体结合抗体,但在献血者中仅57.9%检测到。总体滴度相当低。从患者免疫状态的角度对结果进行了讨论。